JNJ’s Psoriasis Trial Advances

🏥
Clinical Trial — Recruiting Now

🔬 Active Clinical Trial: NCT07665385 | Status: NOT_YET_RECRUITING | Phase: NA

View full trial details on ClinicalTrials.gov →

Comparing Sound and Talk Therapies for Long-Term Tinnitus Relief

A new clinical trial is preparing to directly test two established tinnitus therapies against each other and their combination. Registered as NCT07665385, the study will recruit 60 adults to determine whether Sound Therapy, Cognitive Behavioral Therapy (CBT), or a blend of both is most effective for reducing the severity and distress of chronic subjective tinnitus. This head-to-head comparison is designed to move beyond general recommendations and provide clearer evidence to guide treatment plans.

Key Takeaways

  • The trial will directly compare three treatments for chronic tinnitus: Sound Therapy alone, Cognitive Behavioral Therapy (CBT) alone, and a combined approach.
  • Researchers will measure impact on tinnitus severity, psychological wellbeing, and quality of life in 60 adult participants.
  • Eligible participants must have had tinnitus for over 3 months and have normal to moderate hearing loss.
  • The trial is currently listed as NOT_YET_RECRUITING, with details available on ClinicalTrials.gov.
  • Results could help clinicians prioritize treatment pathways based on comparative effectiveness.

The Structure of the Trial

The study has a straightforward interventional design. Participants will be randomly assigned to one of three groups. Group A will receive Sound Therapy, which typically involves using devices like hearing aids, sound generators, or tabletop sound machines to introduce external noise. The goal is to reduce the perceptual contrast of the tinnitus signal, promoting neural habituation.

Group B will undergo Cognitive Behavioral Therapy. This psychological intervention does not aim to eliminate the tinnitus sound itself but focuses on changing the emotional and cognitive responses to it. Therapists work with patients to identify and modify distressing thought patterns and maladaptive behaviors related to their condition.

Group C will receive the combined protocol, integrating both Sound Therapy and CBT sessions. The primary outcomes the research team will track are changes in tinnitus severity scores, measures of psychological wellbeing, and overall quality of life. The trial is not testing a drug or device, but rather the comparative efficacy of these non-invasive management strategies.

Scientific Rationale for a Combined Approach

Tinnitus is widely accepted as a complex, multifactorial condition. Because there is no universal cure, clinical management focuses on reducing the perception of tinnitus and the distress it causes. Sound Therapy and CBT have formed the backbone of many treatment programs, but they are often used in isolation or without clear data on which to base a choice.

Sound Therapy operates on an auditory and neurological model. By enriching the sound environment, it can decrease the brain’s attention to the internal tinnitus signal, as described by researchers like Hall. Conversely, CBT, which has been detailed by experts such as Andersson, addresses the top-down psychological processes. It helps patients develop coping skills to break the cycle of negative thoughts, anxiety, and attention fixation that amplifies suffering.

The hypothesis driving this trial is that these two methods target different mechanisms—one peripheral/neurological and the other cognitive/emotional. A combined treatment may therefore address the condition more completely than either therapy alone, potentially leading to greater improvements in daily life.

Who Can Participate

The trial has specific criteria to create a homogenous study sample. It seeks 60 adults aged 18 to 65 who have experienced chronic subjective tinnitus for more than three months. Participants must have a stable psychological condition and hearing levels ranging from normal to mild or moderate sensorineural hearing loss. This hearing requirement ensures participants can adequately perceive and benefit from the Sound Therapy component.

Individuals are excluded if they are outside the age range, have severe hearing loss, are diagnosed with objective tinnitus (caused by vascular or muscular issues), have an active psychiatric disorder requiring immediate care, or have active middle or external ear disease.

Current Status and Future Implications

As of now, this trial is listed as NOT_YET_RECRUITING. The official title is “Efficacy of Sound Therapy, Cognitive Behavioral Therapy and Their Combination in Management of Chronic Tinnitus.” Potential participants and referring clinicians should monitor its status on ClinicalTrials.gov for updates on recruitment openings.

The results from this study could have a direct impact on clinical practice. If one approach shows clear superiority, it could streamline treatment pathways. More likely, the data may reveal for which types of patients or tinnitus presentations a specific therapy is most beneficial. Evidence supporting a combined protocol could strengthen the case for integrated, multidisciplinary tinnitus clinics, moving care from a single-modality model to a more personalized, multi-pronged strategy. For patients, the ultimate goal is more precise guidance on which investment of time and resources is most likely to reduce the burden of their tinnitus.

This article is for informational purposes only. Consult a qualified professional for personalised advice.


Source:
Trial of Management of Chronic Tinnitus by Sound Therapy and Cognitive Behavioral Therapy (ClinicalTrials.gov: NCT07665385)

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

⚡ Research Insider Weekly

Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.

No spam. Unsubscribe anytime. Powered by Beehiiv.

Similar Posts